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Background: Sudden cardiac death (SCD) is an unexpected death that occurs within
an hour of the onset of symptoms. Hereditary primary electrical disorders account
for up to 1/3 of all SCD cases in younger individuals and include conditions such
as catecholaminergic polymorphic ventricular tachycardia (CPVT). These disorders are
caused by mutations in the genes encoding cardiac ion channels, hence they are known
as cardiac channelopathies. We identified a novel variant, T1857I, in the C-terminus
of Nav1.5 (SCN5A) linked to a family with a CPVT-like phenotype characterized by
atrial tachy-arrhythmias and polymorphic ventricular ectopy occurring at rest and with
adrenergic stimulation, and a strong family history of SCD.
Objective: Our goal was to functionally characterize the novel Nav1.5 variant and
determine a possible link between channel gating and clinical phenotype.
Methods: We first used electrocardiogram recordings to visualize the patient cardiac
electrical properties. Then, we performed voltage-clamp of transiently transfected
CHO cells. Lastly, we used the ventricular/atrial models to visualize gating defects on
cardiac excitability.
Results: Voltage-dependences of both activation and inactivation were right-shifted,
the overlap between activation and inactivation predicted increased window currents,
the recovery from fast inactivation was slowed, there was no significant difference in
late currents, and there was no difference in use-dependent inactivation. The O’Hara-
Rudy model suggests ventricular after depolarizations and atrial Grandi-based model
suggests a slight prolongation of atrial action potential duration.
Conclusion: We conclude that T1857I likely causes a net gain-of-function in Nav1.5
gating, which may in turn lead to ventricular after depolarization, predisposing carriers
to tachy-arrhythmias.
Keywords: SCN5A, Nav1.5, channelopathy, atrial arrhymia, ventricular arrhythmia
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INTRODUCTION
Sudden cardiac death (SCD) is an unexpected death that occurs
within an hour of the onset of symptoms (Myerburg and
Junttila, 2012; Wellens et al., 2014). SCD is a devastating public
health problem with major social implications and is responsible
for thousands of deaths annually worldwide (Myerburg and
Junttila, 2012). Hereditary primary electrical disorders account
for up to a third of all SCD cases in younger individuals
(Meyer et al., 2012) and include: long QT syndrome (LQTS),
Brugada syndrome (BrS), short QT syndrome (SQT), and
catecholaminergic polymorphic ventricular tachycardia (CPVT)
(Priori and Chen, 2011; Pérez-Riera et al., 2018; Roston et al.,
2018). These disorders are caused by mutations in the genes that
encode cardiac ion channels, hence they are known as cardiac
channelopathies.
CPVT is a malignant inheritable cardiac channelopathy that
is triggered by stress or exertion and is characterized by atrial
tachycardia, polymorphic ventricular arrhythmias and SCD.
Most mutations in patients with CPVT have been reported in
the gene that encodes the cardiac ryanodine receptor (RyR2).
In addition to RyR2, few cases of CPVT have been caused by
mutations in the genes that encode calsequestrin (CASQ2) and
Kir2.1 (KCNJ2) (Priori and Chen, 2011; Pérez-Riera et al., 2018).
The sodium current passing through voltage-gated sodium
channels (Nav) initiates action potentials in excitable cells. Nav
channels are hetero-multimeric proteins composed of large
ion conducting α-subunits and smaller auxiliary β-subunits
(Isom et al., 1992; Catterall, 2012; Calhoun and Isom, 2014;
Ghovanloo et al., 2016b, 2018; Ghovanloo and Ruben, 2020;
Sait et al., 2020). The SCN5A gene encodes Nav1.5, which is
the predominantly expressed Nav in the myocardium (Jiang
et al., 2020). SCN5A mutations have been associated with
LQTS, BrS, cardiac conduction defects, sick sinus syndrome,
and dilated cardiomyopathy (Aiba, 2019). Additionally, Olesen
et al. (2012) determined that a cohort of patients whose SCN5A
mutations were previously associated with LQTS-(subtype 3)
developed early onset lone atrial fibrillation. The biophysical
characterization of these mutations suggested that there is
considerable mechanistic overlap between LQTS-3 and early
onset lone atrial fibrillation, which include alterations to peak
currents, kinetics, and gating properties (Olesen et al., 2012).
This study focuses on a novel mutation, T1857I, in the
C-terminus of Nav1.5 that is linked to a family with an
inherited arrhythmogenic phenotype characterized by atrial
tachy-arrhythmias and polymorphic ventricular arrhythmia
occurring at rest and with adrenergic stimulation, and a strong
family history of SCD, akin to but not typical of CPVT. We




Chinese Hamster Ovary (CHOK1) cells were transiently co-
transfected with cDNA encoding eGFP and the β1-subunit and
either WT or variant Nav1.5 α-subunit. Transfection was done
according to the PolyFect transfection protocol. After each set
of transfections, a minimum of 8 h incubation was allowed
before plating on sterile coverslips. The α:β1:eGFP ratio of
transfection was 1:0.5:1.
Electrophysiology
Whole-cell patch-clamp recordings were performed in an
extracellular solution containing (in mM): 140 NaCl, 4 KCl, 2
CaCl2, 1 MgCl2, 10 HEPES (pH 7.4). Solutions were adjusted to
pH 7.4 with CsOH. Pipettes were filled with intracellular solution,
containing (in mM): 120 CsF, 20 CsCl, 10 NaCl, 10 HEPES. All
recordings were made using an EPC-9 patch-clamp amplifier
(HEKA Elektronik, Lambrecht, Germany) digitized at 20 kHz via
an ITC-16 interface (Instrutech, Great Neck, NY, United States).
Voltage-clamping and data acquisition were controlled using
PatchMaster software (HEKA Elektronik, Lambrecht, Germany)
running on an Apple iMac. Current was low-pass-filtered at
10 kHz. Leak subtraction was performed automatically by
software using a P/4 procedure following the test pulse. Gigaohm
seals were allowed to stabilize in the on-cell configuration for
1 min prior to establishing the whole-cell configuration. Series
resistance was less than 5 M for all recordings. Series resistance
compensation up to 80% was used when necessary. All data
were acquired at least 1 min after attaining the whole-cell
configuration. Before each protocol, the membrane potential was
hyperpolarized to −130 mV to ensure complete removal of both
fast inactivation and slow inactivation. All experiments were
conducted at 22◦C. Glass pipette resistances were∼1.5 M.
Activation Protocols
To determine the voltage-dependence of activation, we measured
the peak current amplitude at test pulse potentials ranging from
−100 to +80 mV in increments of +10 mV for 19 ms. Channel
conductance (G) was calculated from peak INa:
GNa = INa/V− ENa (1)
where GNa is conductance, INa is peak sodium current in response
to the command potential V, and ENa is the Nernst equilibrium
potential. Calculated values for conductance were fit with the
Boltzmann equation:









where G/Gmax is normalized conductance amplitude, Vm is the
command potential, z is the apparent valence, e0 is the elementary
charge, V1/2 is the midpoint voltage, k is the Boltzmann constant,
and T is temperature in K.
Steady-State Fast Inactivation Protocols
The voltage-dependence of fast inactivation was measured by
preconditioning the channels to a hyperpolarizing potential of
−130 mV and then eliciting pre-pulse potentials that ranged from
−170 to+10 mV in increments of 10 mV for 200 ms, followed by
a 10 ms test pulse during which the voltage was stepped to 0 mV.
Normalized current amplitudes from the test pulse were fit as a
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function of voltage using the Boltzmann equation:









where Imax is the maximum test pulse current amplitude.
Recovery From Fast Inactivation
Protocols
Channels were fast-inactivated during a 20 or 200 ms
depolarizing step to 0 mV, and recovery was measured during
a 19 ms test pulse to 0 mV following a −90 mV recovery pulse
for durations between 0 and 1.024 s. Time constants of fast
inactivation recovery showed two components and were fit using
a double exponential equation:
I = Iss + α1 exp (−t/τ1) + α2 exp (−t/τ2) (4)
where I is current amplitude, Iss is the plateau amplitude, α1 and
α2 are the amplitudes at time 0 for time constants τ1 and τ2, and
t is time.
Use-Dependent Inactivation −3 Hz
Channels accumulated into a use-dependent inactivated state
during either a series of depolarizing pulses to 0 mV. Normalized
current amplitude as a function of time was fitted with a
double exponential.
Late Current Protocol
Late current was measured between 145 and 150 ms during a
200 ms depolarizing pulse to 0 mV from a holding potential of
−130 mV. Pulses were averaged to increase signal-to-noise ratio.
Window Current Measurements
Window current areas were analyzed by converting activation
and inactivation curves to precents (Wang et al., 1996)
and calculating the area under both curves by integration
using Microsoft Excel; the position of area peak was
estimated in Igor Pro.
Action Potential Modeling
Ventricular action potentials were simulated using a modified
version of the O’Hara–Rudy model programmed in Matlab
(O’Hara et al., 2011; Fouda et al., 2020). The code that was
used to produce the model is available online from Washington
University in St. Louis1. The modified gating INa parameters
were in accordance with the most relevant biophysical data
obtained from whole-cell patch-clamp experiments in this
study for various conditions, including voltage-dependences of
activation, inactivation, and peak sodium conductance. Atrial
action potentials were simulated using a modified version of the
Grandi model coded in Matlab (Grandi et al., 2011; Morotti et al.,
2016). The original code was acquired from UC Davis2. Original
equations for O’Hara-Rudy:




hss = 1.0/(1.0 + exp((v + 82.9)/6.086)) (6)
and Grandi:
mss = 1.0/((1.0+ exp(−(56.86+ v(39))/9.03))2) (7)
hss = 1.0/((1.0+ exp((v(39)+ 71.55)/7.43))2) (8)
The modifications to the original parameters where based
the magnitude differences between WT and T1557I shown in
Supplementary Tables S1–S6.
Analysis
Analysis and graphing were done using FitMaster software
(HEKA Elektronik) and Igor Pro (Wavemetrics, Lake Oswego,
OR, United States). All data acquisition and analysis programs
were run on an Apple iMac (Apple Computer). Statistical analysis
was performed in JMP version 13.
Statistics
Continuous variables are presented as means ± standard error
in mean and were normally distributed. T-test was used to
compare the mean responses (activation, current density, steady-
state fast inactivation, late currents, use-dependent inactivation,
and fast inactivation recovery) between channel variants (two
levels: WT and T1857I). A level of significance α = 0.05 was used




The T1857I mutation was identified in two sisters at the
ages of 14 and 16 years. The SCN5A variant was identified
on a 165 comprehensive cardiac next generation sequencing
(NGS) gene panel. The panel included known arrhythmia and
cardiomyopathy genes. There was no history of arrhythmic
syncope or seizure. The family history (Figure 1) was relevant
for SCD in the mother at the age of 21 years and in the
maternal grandmother at the age of 48 years, both occurring
at rest. The remaining maternal family history is relevant
for multiple individuals with early onset atrial fibrillation and
SCD at a young age. Investigations included serial ECGs,
signal average ECGs, high-lead ECGs, exercise stress tests, 24
h Holter monitoring, echocardiograms, and cardiac magnetic
resonance imaging. These investigations demonstrated a pattern
of progressively increasing burden of atrial and ventricular
ectopy and non-sustained tachycardia of post-pubertal onset. The
arrhythmias worsened with exercise but were also ambient at
baseline. Criteria were not met for any cardiac channelopathy,
specifically a normal QTc at baseline and in recovery on exercise
stress test, no evidence of Brugada like changes, no pathologic
early repolarization, as well as no evidence of cardiomyopathy.
The clinical characteristics were suggestive of an atypical
CPVT-like phenotype. A broad arrhythmia genetic screening
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FIGURE 1 | Pedigree of the T1857I Variant in Nav1.5.
panel was performed, identifying the novel T1857I mutation
in both siblings.
During 5 years of follow-up, both siblings developed a very
similar phenotype with frequent catecholamine sensitive atrial
and polymorphic ventricular ectopy with non-sustained atrial
tachycardia up to 200 bpm along with bidirectional PVCs
and polymorphic triplets. The arrhythmias are only partially
responsive to Nadolol and were thought to be minimally
responsive to Flecainide. A sample ECG is shown in Figure 2A
showing sinus rhythm with frequent polymorphic premature
wide complex beats, depolarization abnormality with low T-wave
amplitude and inverted T-waves in the right precordial leads
(V1 and V2), and otherwise normal intervals. Twenty-four-hour
Holter monitoring revealed patterns consistent with CPVT-like
pathology. Figure 2B shows a non-sustained irregular narrow
complex tachycardia suspected to be atrial tachycardia, and
Figure 2C shows bidirectional PVCs, which usually raise the
suspicion for CPVT.
T1857I Depolarizes Activation, Increases
Apparent Valence
We conducted whole-cell patch-clamp experiments to investigate
whether the T1857I variant in the C-terminus alters the
biophysical properties of Nav1.5. We examined the variant effect
on channel activation in WT and T1857I by measuring peak
channel conductance at membrane potentials between−100 and
+80 mV (Figures 3A,B). We found that the mutation causes
a significant shift on the midpoint (V1/2) of the conductance
curve (p = 0.0069) in the depolarized direction. T1857 also causes
a significant increase in the apparent valence (z) of activation
(p = 0.0317) (Supplementary Table S1). This suggests that this
C-terminal mutation has a destabilizing effect on the voltage-
dependence of activation and also affects magnitude of charge
movement during activation.
T1857I Decreases Peak Current Density
We measured current density from the ratio of peak current
amplitude to the cell membrane capacitance (pA/pF)
(Figure 3C). As variant activation curve was right-shifted
compared to WT, we measured the peak current densities
at −20 mV (where WT elicits maximal current) and 0 mV
[where T1857I elicits maximal current (Figure 3B)]. Our results
suggested that the T1857I variant channels had significantly
smaller current densities than WT at both potentials (p< 0.0001)
(Figure 3C and Supplementary Table S2).
T1857I Depolarizes Steady-State Fast
Inactivation (SSFI)
We measured the voltage-dependence of SSFI using a standard
200 ms pre-pulse voltage protocol. Normalized current
amplitudes were plotted as a function of pre-pulse voltage
(Figure 3D and Supplementary Table S3). Our results indicate
T1857I significantly destabilizes the V1/2 (p < 0.0001), but not
the z (p > 0.05) of the voltage-dependence of SSFI. This indicates
that at any given potential the variant channels are less likely to
fast inactivate, suggesting an increased excitability.
T1857I Slows Recovery From Inactivation
One benchmark of Nav is the rate at which they recover from
inactivation. To measure recovery, we held Nav1.5 at −130 mV
to ensure channels were fully available, then pulsed the channels
to 0 mV for 500 ms and allowed different time intervals at
−130 mV to measure recovery as a function of time (Figure 4A
and Supplementary Table S4). Our results indicate that T1857I
variants have a relatively slowed rate of recovery from fast
inactivation (p < 0.05).
T1857I Does Not Alter Use-Dependent
Inactivation
To understand the effects of elevated heart rate on channel
function, we elicited use-dependent inactivation at 3 Hz.
Normalized currents from 3 Hz use-dependent inactivation
protocols are plotted against time in Figure 4B for both the
channel variants. We found that there are no significant
differences between WT and T1857I in use-dependent
inactivation rates (p > 0.05) (Supplementary Table S5).
T1857I Does Not Alter Late Currents,
Increases Window Currents
Total sodium current can be divided into two components: peak
(INaP) and late (INaL) currents. Whereas INaP refers to the
maximum amount of sodium ions going through the channels
during the open state, the smaller INaL is a manifestation of
destabilized fast inactivation and has been shown to underlie
LQT syndromes (Wang et al., 1995; Jarecki et al., 2010;
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A B C
FIGURE 2 | ECGs/Relevant Clinical Data. (A) Standard 12-lead ECG obtained from the patient with the novel SCN5A mutation. Sinus rhythm with frequent
polymorphic premature wide complex beats, low T-wave amplitude and inverted T-waves in the right precordial leads (V1 and V2), normal axis and QRS duration and
QTc = 396. (B,C) Segments from 24 h Holter monitoring. (B) Shows a non-sustained irregular narrow complex tachycardia suspected to be atrial tachycardia.
(C) Shows bi-directional PVCs.
A B
C D
FIGURE 3 | Comparison of the Voltage-Dependence of Activation/Fast Inactivation Between WT and T1857I. (A) Voltage-dependence of activation as normalized
conductance plotted against membrane potential. Sample macroscopic sodium currents elicited by depolarizations between −100 and +80 mV (reversal potential:
WT = 49.7 ± 4 mV, TI = 59.5 ± 2 mV). (B) Normalized current and voltage relationship. Each recording was normalized relative to its own maximal peak value. The
normalized current and voltage relationships shown are averaged for each condition. (C) Average current (Y-axis) density of WT and T1857I.
(D) Voltage-dependence of steady-state fast inactivation as normalized current plotted against membrane potential. ** and ## represent statistical significance.
Ghovanloo et al., 2016a; Ghovanloo and Ruben, 2020). We
show representative current traces for both channels across
all conditions (Figure 4C and Supplementary Table S6). We
measured the percentage of INaL by dividing the maximum
INaL between 145 and 150 ms by INaP and found that there
is no significant difference in the percentage of late currents
between WT and T1857I. This is consistent with the normal QTc
observed in the patient.
Changes in the voltage-dependence of both steady-state
activation and fast inactivation may lead to differences in the
window current. Consistent with the large right-shift of the SSFI
curve, we found that T1857I has an increased sodium window
current compared with WT-Nav1.5. We also found that the
window current period was right-shifted in T1857I compared to
WT (Figure 4D).
T1857I Causes After Depolarizations in
the O’Hara–Rudy Model of Ventricular
Cardiac Excitability
We used the O’Hara–Rudy model to simulate cardiac action
potentials (AP) (pacing cycle length 1,000 ms) and measure the
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A B
C D
FIGURE 4 | Comparison of Fast Inactivation Recovery, Use-Dependence, Persistent Currents, and Window Currents. (A) Recovery from fast inactivation.
(B) Use-dependent inactivation at 3Hz. Show normalized current decay plotted as a function of time. (C) Representative current traces of late currents in WT and
T1857I. Average late sodium current as a percentage of peak sodium current. (D) Window currents obtained from the overlap of the GV and SSFI curves shown in
Figures 3A,D. The curves shown are the Boltzmann fits of the data. The dashed lines show the approximate window peak, on a Y-axis that is converted to
percentage as described in Wang et al. (1996). The peak for WT is reached at −70 mV and 7.4%, and for T1857I at −45 mV and 10.9%. The window area for
T1857I is about 62% bigger than WT.
effect of the T1857I mutation (O’Hara et al., 2011). The control
results from the patch-clamp experiments were adjusted to the
original model parameters and the subsequent magnitude shifts
in the simulations of the mutation were performed relative to the
original model parameters (Figure 5).
The smaller current densities in T1857I (Figure 3C) could
have two possible underlying causes: (1) the variant biophysically
alters and reduces the sodium conductance, (2) the variant
construct has a smaller expression/trafficking, hence the smaller
sodium conductance in patch-clamp experiments is an artificial
effect. Therefore, we performed two sets of simulations for
T1857I. In Figure 5A, we show an AP simulation where we
reduced the sodium conductance by sixfold, which is consistent
with the current density data shown in Figure 3C. The
results from this condition show reduction in the upstroke
velocity and peak amplitude of phase 0, and a slight after
depolarization hump that starts at ∼250 ms. In Figure 5B,
we left the sodium conductance unchanged in T1857I. In
this simulation, a more pronounced after depolarization was
observed starting at ∼225 ms. Overall, both sets of simulations
suggest that T1857I causes after depolarizations, which could lead
to cardiac arrhythmias.
To examine possible variant effects on different ventricular
cell types, we compared simulated APs between endocardium,
epicardium, and myocardium. After depolarizations are observed
in all three cell types (Figures 5C–E). Also, as our patients
are heterozygotes (maternal inheritance of the variant allele),
we performed all simulations with a heterozygous assumption
(i.e., 50% of the channels have the variant phenotype and 50%
are WT). The AP morphology of the heterozygous simulations
appear less exaggerated than the pure T1857I conditions, and
therefore may be a better representation of ventricular excitability
in our patients, congruent with the normal QRS duration on
baseline ECG in both patients.
T1857I Causes Slight GOF in Atrial
Grandi Model of Cardiac Excitability
To investigate possible T1857I effects on atrial excitability, we
ran atrial AP simulations using the Grandi model (Grandi et al.,
2011; Figures 6A–D). Similar to the ventricular APs, reducing the
sodium conductance lowered the AP peak and slightly prolonged
the APD (Figure 6A). However, in the simulations in which
the sodium conductance remained unchanged, the variant effects
were minimal (Figure 6B). Furthermore, there were virtually
no differences in the variant effect between atrial epicardium
and endocardium simulations (Figures 6C,D), and these effects
became even more subtle in heterozygote conditions. Overall,
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A B
C D E
FIGURE 5 | O’Hara-Rudy-Based Ventricular Action Potential Model. Comparison of the action potential between WT and T1857I. The changes to conductances
were based on experimental data obtained from patch-clamp results. (A) Changed gNa, (B) Unchanged gNa. (C–E) Endocardium/epicardium/myocardium
simulations with WT, T1857I, and Heterozygote (unchanged gNa).
based on the Grandi model, the effect of T1857I on atrial
excitability is predicted to be minimal.
DISCUSSION
Possible Underlying Mechanisms and
Implications
We identified a novel variant, T1857I, explored its effects on
the biophysical properties of Nav1.5, and used the results to
simulate cardiac action potentials. Our results suggest that
the voltage-dependence of both activation and inactivation
are right-shifted. The right-shift of activation suggests a loss-
of-function, in contrast the larger right-shift of inactivation
suggests a gain-of-function in this channel. We also found that
the recovery from fast inactivation was slowed. To determine
the effects of gating shifts in T1857I, we first introduced the
relevant experimental data into the ventricular O’Hara-Rudy
model, which suggests after depolarizations may result. We then
performed atrial AP modeling using the Grandi model, which
suggested minimal variant effects. Thus, we conclude that T1857I
likely causes a net gain-of-function in the Nav1.5 gating, with
an increased window current and resultant ventricular tissue
after depolarization, which could lead to arrhythmias. These
biophysical properties of after depolarization, unaltered late Na+
current and unchanged AP duration are, respectively, consistent
with the clinical phenotype of the probands characterized
by frequent and polymorphic ventricular ectopy and tachy-
arrhythmia, normal QTc and QRS duration.
The inward sodium current through Nav1.5 is the principal
determinant of Vmax inside the myocardium. The functional
differences in human atrial and ventricular sodium current
biophysical properties were suggested to be minimal (Sakakibara
et al., 1992, 1993; Jia et al., 1993; Furukawa et al., 1995).
Although Nav1.5 is the predominant Nav channel in the heart,
the transcript for the sodium channel auxiliary β1-subunit is
more highly expressed in the atrium (Gaborit et al., 2007).
Recent structural studies determined the structural basis for a
reduced modulation of Nav1.5 by β1-subunits. They suggested
that the sodium current amplitude differences between atrial
and ventricular cells are unlikely to be significantly affected
by β1-subunits expression levels (Ghovanloo and Ruben, 2020;
Jiang et al., 2020). Additionally, reports in canine atrial cells
suggest that the atria have a larger sodium current density and a
hyperpolarized inactivation compared to ventricles (Burashnikov
et al., 2007). Also, due to the depolarized resting membrane
potential, there is less sodium channel availability in the atria
compared to the ventricle, and hence, the resulting sodium
current underlying the atrial action potential is smaller in
atrial cells (Gui-Rong and Nattel, 1997). In contrast to the
sodium current, several other ionic currents display more
pronounced differences. These differences underly the difference
in action potential morphology between these cell types (Pandit,
2018). These differences may also be the reason for the less
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A B
C D
FIGURE 6 | Grandi-Based Atrial Action Potential Model. Comparison of the action potential between WT and T1857I. The changes to conductances were based on
experimental data obtained from patch-clamp results. (A) Changed gNa, (B) Unchanged gNa. (C,D) Endocardium/epicardium simulations with WT, T1857I, and
heterozygote (unchanged gNa).
pronounced T1857I experimentally simulated effects in atria
compared to ventricles (Figures 5, 6). Our modeling did not
account for recovery from inactivation, which is a limitation of
our simulations.
The sodium/calcium exchanger (NCX) plays a vital role in
maintaining cellular calcium levels. NCX takes advantage of
higher extracellular sodium concentrations to pump calcium
out of the cytosol. However, the NCX also functions in
reverse mode (Satoh et al., 2000; Priori and Chen, 2011).
The human atrial action potential is also modulated by
intracellular calcium concentrations, which can directly affect
calcium channel inactivation (Nattel, 1997) that modulates the
timing and size of NCX current (Bénardeau et al., 1996; Li
and Nattel, 1996). Our results suggest that the most notable
biophysical property of T1857I is its ∼30 mV right-shifted
SSFI. This large shift increases the overlap (window current)
between the SSFI and activation curves in T1857I. The elevated
window current may explain the after depolarizations observed
in our AP simulations. Given this SSFI curve, at any given
membrane potential, more sodium influx into the cytosol is
expected. In turn, this may induce reverse mode NCX activity
leading to Ca2+ entry and give rise to after depolarizations in
both atrial and ventricular myocytes. This hypothesis merits
further investigations through measurement of NCX activity in
cardiac myocytes.
The phenotypic expression of T1857I is similar to that
of R222Q, which underlies multifocal ectopic Purkinje-related
premature contractions (MEPPC) (Laurent et al., 2012). Both
disorders include atrial arrhythmias, premature ventricular
contractions, and may result in SCD. However, the biophysical
underpinnings of the two syndromes are quite different.
Although both R222Q and T1857I cause a depolarizing shift in
the voltage-dependence of activation, our results with T1857I
also show a depolarizing shift in SSFI, whereas R222Q causes
a small hyperpolarizing shift in inactivation. Furthermore, the
in silico action potentials have different morphologies arising
from the two mutations. A more recent study reported another
MEPPC-causing mutation, G213D, that similar to T1857I
right-shifted inactivation; however, unlike T1857I, the G213D
activation curve was left-shifted (Calloe et al., 2018). These
differences underscore the novelty of our clinical and biophysical
observations related to T1857I.
Rationale for Using CHO Cells for T1857I
Characterization
In this study, our experiments were performed using CHOK1
cells, which are a heterologous expression system. CHO
cells have small background currents and are excellent for
studying channels using transient transfections. Navs are typically
modulated by several proteins and accessory subunits which
could be missing in heterologous systems. However, despite these
limitations, heterologous systems work like blank canvases that
are the gold standard for purely biophysical studies such as those
presented here. Although induced pluripotent stem cells (iPSC)
are generally considered more physiological than CHO cells, they
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do not fully recapitulate intact human cells (Knollmann, 2013;
Goversen et al., 2018). For instance, iPSC-derived cells are
often immature and lack various critical structures (Knollmann,
2013; Goversen et al., 2018). Furthermore, these cells are
inadequate for studying the biophysical properties of any
given channels and may therefore reduce reproducibility.
Furthermore, studying the properties of a single channel
type (in this case to isolate Nav1.5) requires using elaborate
pharmacological cocktails which may introduce confounding
effects. To that end, to reduce the confounding effects of
the complex genetic background and need for extensive
channel blockers, we performed our studies in the simple
CHO cells, which enabled a deep understanding of the
electrophysiology of T1857I, and we applied that info to
well-established cardiac models to visualize the mutant
effects on gating.
CONCLUSION
In conclusion, we report a novel SCN5A mutation encoding
T1857I where afflicted probands present with clinically
characterizable incidence of atrial and ventricular arrhythmias
and multiple familial sudden deaths. The biophysical
characterization of this variant indicates a mixture of
gain- and loss-of-function effects. Computer simulations
using the experimental data suggest after depolarizations
as the net result. These mechanistic findings are consistent
with the clinically observed cardiac arrhythmias in the
affected probands.
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